首页> 中国专利> 带有一氧化氮供体的芳香酸衍生物在制备治疗恶性肿瘤迁移疾病药物中的应用

带有一氧化氮供体的芳香酸衍生物在制备治疗恶性肿瘤迁移疾病药物中的应用

页面导航

摘要
著录项
法律信息
相似文献

摘要

本发明公开了带有一氧化氮供体的芳香酸衍生物在制备治疗恶性肿瘤迁移疾病药物中的新应用，本发明在现有技术的基础上，通过大量实验研究，开发新的临床功效，实验结果表明，带有一氧化氮供体的芳香酸衍生物具有很好的抑制肿瘤细胞生长，尤其是具有很好的抑制肿瘤细胞迁移的功效，疗效可靠，安全性好，具有重要的应用前景。

著录项

公开/公告号CN105832727B

专利类型发明专利
公开/公告日2018-12-11

原文格式PDF
申请/专利权人南京中医药大学;
展开▼

申请/专利号CN201610301604.9
发明设计人唐于平;章鹏轩;李念光;段金廒;
展开▼

申请日2016-05-06
分类号
代理机构南京经纬专利商标代理有限公司;
代理人杨海军
地址 210000 江苏省南京市栖霞区仙林大道138号
入库时间 2022-08-23 10:21:58

法律信息

法律状态公告日

法律状态信息

法律状态
2018-12-11

授权

授权
2016-09-07

实质审查的生效 IPC(主分类):A61K31/4245 申请日:20160506

实质审查的生效
2016-09-07

实质审查的生效 IPC(主分类):A61K 31/4245 申请日:20160506

实质审查的生效
2016-08-10

公开

公开
2016-08-10

公开

公开

相似文献

专利
中文文献
外文文献

1. 带有一氧化氮供体的芳香酸衍生物在制备治疗恶性肿瘤迁移疾病药物中的应用 [P] . 中国专利： CN105832727B . 2018.12.11
2. 带有一氧化氮供体的芳香酸衍生物在制备治疗恶性肿瘤疾病药物中的应用 [P] . 中国专利： CN102784134B . 2014.04.09
3. Immunoconjugate, methods for treating multiple myeloma in an individual, for dispensing immunoconjugate-mediated drug, for inhibiting, delaying and / or preventing tumor development and / or dispensing malignant tumor cells in a patient in need thereof, for treating an individual having a condition and to decrease the amount of cells in direct or indirect contact with immunoconjugates, a method for treating multiple myeloma in an individual, to dispense immunoconjugate-mediated medication, to inhibit, delay and / or prevent tumor cell development in a cell culture, to inhibit, delay and / or prevent the development of a tumor and / or dispense malignant tumor cells in a patient in need thereof, to treat an individual having a condition and to decrease a number of cells in direct or indirect contact. with tumor cells, pharmaceutical composition, and kit. [P] . BRPI0821449A2 . 2015-06-16

机译：免疫缀合物，用于在个体中治疗多发性骨髓瘤的方法，用于分配免疫缀合物介导的药物，用于在需要其的患者中抑制，延迟和/或预防肿瘤的发展和/或分配恶性肿瘤细胞，用于治疗患有以下疾病的个体：为了减少与免疫缀合物直接或间接接触的细胞数量，一种用于治疗个体多发性骨髓瘤，分配免疫缀合物介导的药物，抑制，延迟和/或预防细胞培养中肿瘤细胞发展，抑制，在有需要的患者中延迟和/或预防肿瘤的发展和/或分配恶性肿瘤细胞，以治疗患有某种疾病的个体并减少直接或间接接触的细胞数量。带有肿瘤细胞，药物成分和试剂盒。
4. DNA was isolated and purified, peptu00ecdeo, sequences of amino acids of human and murine sphk2, construction of recombinant DNA, host cell.Methods for producing a peptu00ecdeo of sphingosine kinase type 2 isoform of mouse and human.And to detect an agent or a drug that inhibits or promotes the activity of sphingosine kinase type 2, agent or product, methods for regulating a biological process in a mamu00ecfero,For the treatment or the improvement of a disease resulting from cell death increased or reduced cell proliferation.For the treatment or management of a disease resulting from reduced cell death or cell proliferation increased.And for the treatment or the improvement of a disease resulting from abnormal migration or motility of cells selected from the group consisted of cancer, restenose and diabetic neuropathy.Composition for the treatment or the improvement of UIMA disease resulting from cell death increased or reduced cell proliferation.Methods for screening for agents or [P] . BR0109827A . 2004-07-06

机译：分离纯化DNA，肽，人和鼠sphk2的氨基酸序列，重组DNA的构建，宿主细胞。小鼠和人2型鞘氨醇激酶2型亚型的肽的制备方法，并检测抑制或促进2型鞘氨醇激酶活性的药物或药物，药物或产物的调节方法，用于治疗哺乳动物的生物学过程的方法，用于治疗或改善由细胞死亡引起的疾病的方法，增加或减少的细胞增殖用于治疗或管理由减少的细胞死亡或细胞增殖引起的疾病，以及用于治疗或改善由癌症，再狭窄和糖尿病性神经病变组成的组中的细胞异常迁移或运动导致的疾病。用于治疗或改善由细胞死亡引起的UIMA疾病的组合物可增加或减少细胞增殖。
5. composition, pharmaceutical composition, effervescent dosage form, multiple unit oral oral pharmaceutical composition, extended release pharmaceutical dosage form, enteric coated pharmaceutical dosage form, stable pharmaceutical dosage form for oral administration to mammalian subjects, method for treating diseases acid-related diseases by inhibiting gastric acid secretion, method for treating a bacterial infection caused or caused by helicobacter pylori, process for preparing a compound of formula 3, process for preparing a compound of formula 5, use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion, use of a compound of formula 1 for the preparation of a medicament for treating a bacterial infection caused or caused by helicobacter pyl or use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion [P] . BRPI0617987A2 . 2011-08-16

机译：组合物，药物组合物，泡腾剂型，多单位口服口服药物组合物，缓释药物剂型，肠溶衣药物剂型，向哺乳动物受试者口服给药的稳定药物剂型，通过抑制胃酸治疗疾病的方法酸分泌，治疗由幽门螺杆菌引起或引起的细菌感染的方法，制备式3化合物的方法，制备式5化合物的方法，式1化合物在制备用于治疗胃的药物中的用途通过抑制胃酸分泌来治疗与酸有关的疾病，将式1的化合物用于制备用于治疗由幽门螺杆菌引起或引起的细菌感染的药物，或将式1的化合物用于制备用于治疗的药物通过抑制胃酸分泌来治疗胃酸相关疾病